Somatropin - HGH Anti Aging Treatment

home
Anti Aging Anti Aging Research Anti Aging Products Anti Aging Treatment Buy HGH Products

 

Somatropin hgh somatropin treatment for growth hormone deficiency

 
somatropin hgh anti aging treatment

Somatropin - HGH Anti Aging Treatment

Somatropin (hgh) Anti Aging Treatment up until the mid 1980's came from the pituitary glands of cadavers obtained mostly from Africa. In the mid 1980's cadaver somatropin (hgh) Anti Aging Treatment was pulled off the market after it was found to cause a rare disease called Creutzfeld-Jacob disease in the patients, mostly children, who were administering it.

In 1985 the Eli Lily pharmaceutical company managed to synthetically copy the DNA of somatropin (hgh) Anti Aging Treatment Hormone exactly in their lab which the human body naturally produces. Since then the only somatropin (hgh) Anti Aging Treatment Hormone available has been, and still is, recombinant (biosynthetic). Human growth hormone (HGH), generic name - Somatotropin, or Somatropin or Somatotrophin and is only available in an injectable form.

1985, Keith Kelley, M.D., a research scientist demonstrated that injections of cells that secrete high amounts of somatropin (hgh) Anti Aging Treatment Hormone could cause the shriveled thymus glands in old rats to grow until they became as large and healthy as those of young rats. The thymus gland is the primary organ of the immune system. Immune system enhancement as a result of an increased level of somatropin (hgh) Anti Aging Treatment Hormone include the following: increased maturation of neutrophils; higher activity of natural killer cells; stimulation of macrophages;. increased production of red blood cells; the manufacture of new antibodies; increased production of T-cells and interleukin 2; and the greater proliferation and activity of lymphocyte cells.

Somatropin (hgh) Anti Aging Treatment Hormone is a protein molecule consisting of 191 amino acids. Genetic engineering, a new technology that emerged in the 1970's, enables researchers to splice human genes. The process of gene splicing enabled researchers to clone the somatropin (hgh) Anti Aging Treatment Hormone protein after identifying its exact sequence of DNA. After the growth hormone protein was cloned, it was then produced in drug laboratories in commercial quantities. Consequentially, biosynthetic somatropin (hgh) Anti Aging Treatment Hormone began to be available to medical researchers for the first time in the 1980's. This genetically engineered recombinant somatropin (hgh) anti aging growth hormone is completely identical to the somatropin (hgh) human growth hormone naturally produced by the human pituitary gland and is therefore referred to as a natural hormone.

Dr. Daniel Rudman, an endocrinologist and medical researcher from Madison, Wisconsin, conducted the original and remarkable research on the effect of somatropin (hgh) anti aging growth hormone replacement therapy in humans. By the time Dr. Rudman began his work in the mid-1980's, the safety of growth hormone had already been well established through its use in children with (hgh) human growth hormone deficiency. Dr. Rudman believed that the changes in body composition which become apparent around age 35 had to do with declining hormone levels. The only method of testing his hypothesis was to replace somatropin (hgh) Anti Aging Treatment Hormone in deficient elderly adults to ascertain if the anti aging growth hormone replacement reversed some of the effects associated with aging. If somatropin (hgh) Anti Aging Growth Hormone replacement reversed the changes in body composition (ratios of body fat and lean body mass to total body weight) associated with aging, then somatropin (hgh) anti aging growth hormone treatment might reverse the loss of bodily structure and function that occurs with aging.

To test his theory, Dr. Rudman began a study by replacing somatropin (hgh) anti aging growth hormone in a group of older men to examine its effects on lean body mass and body fat in elderly adults. Dr. Rudman studied 26 men between the ages of 61 and 80 who had experienced significant adverse changes in body composition with age, but who were otherwise healthy. These men were overweight and had significantly low levels of somatropin (hgh).

Dr. Rudman selected somatropin (hgh) anti aging growth hormone as the initial hormone to be replaced for two reasons. First, he was aware that the decline in somatropin (hgh) growth hormone after age 35 was generally accompanied by an increase in body fat and a decline in lean muscle mass. Secondly, medical researchers in Sweden and Denmark had already determined that patients who were deficient in somatropin (hgh) growth hormone due to pituitary dysfunction and had received somatropin (hgh) anti aging growth hormone replacement treatment became leaner without altering their lifestyles, diets or exercise programs, the men in Rudman's who received somatropin (hgh) anti aging growth hormone replacement gained an average of 9% in lean muscle mass while losing 14% of body fat during their six month test. Bone density increased and their skin became thicker and firmer. According to Rudman, the men who received somatropin (hgh) anti aging growth hormone replacement treatment during the six months study experienced a reversal of the effects of aging by 10 to 20 years. Dr. Rudman concluded "The overall deterioration of the body that comes with growing old is not inevitable."

Rudman's study, published in The New England Journal of Medicine in 1990, constituted a tremendous scientific breakthrough in the field of rejuvenation medicine. The magnitude and the far reaching impact of Rudman's published study has yet to be determined. For the first time, medical science, empowered with the recently developed genetically engineered recombinant somatropin (hgh) anti aging growth hormone had discovered a means for reversing the effects of aging in humans. The course of the future and history for mankind was forever altered.

Dr. Rudman inspired research scientists and physicians worldwide to investigate and research the use of somatropin (hgh) anti aging growth hormone replacement therapy to reverse the effects of aging and treat diseases associated with aging. Concurrent with the time of Dr. Rudman's study, medical researchers in England, Sweden and Denmark were also discovering with consistency the remarkable effects of somatropin (hgh) anti aging growth hormone replacement treatment. Providing patients with (hgh) growth hormone deficiencies arising from pituitary disease with somatropin (hgh) anti aging growth hormone treatment had a remarkable impact upon such patients. These patients had been depressed, experiencing low vitality, fatigue, anxiety, loss of sex drive and were dying prematurely at twice the average rate due to cardiovascular disease and other problems prior to use of somatropin (hgh) anti aging growth hormone. Somatropin (hgh) anti aging growth hormone replacement treatment brought the patients out of their depression and fatigue into higher quality, productive and happy lives.

In 1996, the New England Journal of Medicine, reported somatropin (hgh) anti aging hormone replacement treatment had reversed heart failure. Today the National Institute On Aging is conducting six clinical trials in a multimillion dollar study of somatropin (hgh) anti aging growth hormone replacement treatment to further confirm that somatropin growth hormone retards and reverses aging.

In August 1996, the Food and Drug Administration approved the use of somatropin (hgh) anti aging growth hormone in adults with growth hormone deficiency due to pituitary or hypothalamic disease, injury, surgery or radiation therapy. Since the studies conducted in England, Sweden and Denmark since 1985 clearly demonstrate that aging is a pituitary disease, the recent FDA approval of adult somatropin (hgh) anti aging growth hormone replacement treatment may now allow physicians in the United States to prescribe somatropin (hgh) anti aging growth hormone for adults with low levels of IGF-1, without knowing why there is a failure of the pituitary gland to produce adequate amounts of (hgh) human growth hormone. This is a legal rather than a medical question.

The FDA approved adult human growth hormone (hgh) replacement treatment for adults with human growth hormone hgh deficiency syndrome after reviewing clinical data submitted to it by the Eli Lilly Company. Lilly secured FDA approval for adult human growth hormone (hgh) replacement therapy because data secured from Lilly's clinical trials demonstrated that somatropin anti aging growth hormone (hgh) replacement treatment resulted in an increase of lean muscle mass, a decrease in body fat, an increase in exercise capacity and an increase in quality of life among adults with human growth hormone (hgh) deficiency. More info on Somatropin HGH -Anti Aging Treatment.>>>


Somatropin - HGH - Anti Aging Treatment

   Anti Aging HGH
   Anti Aging HGH Research
   Injectable Anti Aging Products
   Anti Aging Treatment
   Anti Aging Health Faqs
   Anti Aging Products and Pricing
   Anti Aging Supplements
    • Saizen HGH for Anti Aging
    • Serostim HGH for Anti Aging
    • Saizen one.click pen for Aging
    • Humatrope hgh for Anti Aging
    • Somatropin hgh for Anti Aging
   Customer Service
 Links
 Email This Page to a Friend
Somatropin anti aging hormone
buy somatropin for anti aging
injectable somatropin products
Saizen hgh fro anti aging
Somatropin for anti aging
injectable human growth hormone products
one click hgh saizen anti aging
Somatropin anti aging growth hormone
Serostim antiaging growth hormone
antiaging products
anti aging treatment therapy
Click here to track
you HGH shipment
buy somatropin antiaging online buy somatropin anti aging order anti aging hormone somatropin
Anti Aging Anti Aging Research Anti Aging Products Anti Aging Treatment Buy HGH Products

Somatropin - HGH Anti Aging Treatment

Somatropin hgh Human Growth Hormone information and research on this website is from clinical studies and other resources. This Somatropin Human Growth Hormone, hgh is for informational purposes only. Humatrope, Saizen, and Serostim(R) is a registered trademark of Serono Laboratories and Eli Lilly and Company. HGH-HUMANGROWTHHORMONE or Quality of Life Inc are not associated in any way with Serono Laboratories or Serono's websites, Eli Lilly or Lilly's humatrope.com website. Humatrope, Saizen, Serostim, Human Growth Hormone, Hgh, (somatropin [rDNA origin] for injection) is a prescription medicine FDA approved to treat growth failure due to Somatropin Human Growth Hormone, hgh deficiency in children and short stature associated with Turner syndrome, and as a Human Growth Hormone hgh replacement therapy in adults with Somatropin Human Growth Hormone, HGH deficiency who meet certain specific clinical and biochemical criteria. Serostim (somatropin) Human Growth Hormone Hgh is prescribed for patients with HIV related symptoms. Only your physician can decide if Humatrope, Saizen, Serostim, Somatropin, Human Growth Hormone, or Hgh is appropriate for you.